European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines
This overview of the 2025 EAU guidelines offers valuable insights into risk factors, diagnosis, classification, treatment, and follow-up of MIBC patients and is designed for effective integration into clinical practice.
Authors
- Param Mariappan
- Mithun Kailavasan (ORCID: https://orcid.org/0000-0002-5595-3541)
- Laura S. Mertens (ORCID: https://orcid.org/0000-0003-3317-6427)
- Y. Neuzillet (ORCID: https://orcid.org/0000-0003-4345-3598)
- Valeria Panebianco (ORCID: https://orcid.org/0000-0001-8466-918X)
- Albert Carrión (ORCID: https://orcid.org/0000-0002-4639-1532)
- Rainer Fietkau (ORCID: https://orcid.org/0000-0001-8295-7145)
- George N. Thalmann (ORCID: https://orcid.org/0000-0002-1908-3286)
- Alberto Martini (ORCID: https://orcid.org/0000-0003-1272-7154)
- Richard P. Meijer (ORCID: https://orcid.org/0000-0003-2510-7982)
- Anja Lorch (ORCID: https://orcid.org/0000-0003-1681-3287)
- Antoine G. van der Heijden (ORCID: https://orcid.org/0000-0002-8839-8601)
- Jason A. Efstathiou (ORCID: https://orcid.org/0000-0003-0996-0350)
- Richard Cathomas (ORCID: https://orcid.org/0000-0002-9677-9885)
- Éva Compérat (ORCID: https://orcid.org/0000-0001-8488-543X)
- Michael Rink (ORCID: https://orcid.org/0000-0001-5403-7915)
- Matthew I. Milowsky (ORCID: https://orcid.org/0000-0002-8965-8129)
- Harman Max Bruins
- Konstantinos Dimitropoulos (ORCID: https://orcid.org/0000-0001-7090-7327)
- Sæbjørn Sæbjørnsen
- Emma Jane Smith (ORCID: https://orcid.org/0000-0001-6678-1514)
Institutions
- University of North Carolina at Chapel Hill (US)
- Universitat Autònoma de Barcelona (ES)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Université de Versailles Saint-Quentin-en-Yvelines (FR)
- Western General Hospital (GB)
- Aberdeen Royal Infirmary (GB)
- European Association of Urology (NL)
- University Hospital of Bern (CH)
- Vienna General Hospital (AT)
- Edinburgh Cancer Research (GB)
- The Netherlands Cancer Institute (NL)
- University Medical Center Utrecht (NL)
- Massachusetts General Hospital (US)
- University Hospital of Zurich (CH)
- Victoria Hospital (CA)
- Marienkrankenhaus Hamburg (DE)
- Zuyderland Medisch Centrum (NL)
- Kantonsspital Graubünden (CH)
- UNC Lineberger Comprehensive Cancer Center
- University of Cincinnati (US)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- European Urology
- Published
- 2025-03-20
- DOI
- https://doi.org/10.1016/j.eururo.2025.02.019
- Citations
- 121
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 240.77
Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Sanofi
- Gilead Sciences
- Clovis Oncology
- Mirati Therapeutics
- Incyte
- G1 Therapeutics
- Seagen
- European Association of Urology
- Eisai
- Astellas Pharma
- Ipsen
- Medac
- Genentech
- Sanofi Pasteur